Development of cancer chemopreventive agents: Oltipraz as a paradigm

Chemical Research in Toxicology

Volumn 12, Issue 2, 1999, Pages 113-126

  Kensler, Thomas W ^a   Groopman, John D ^a   Sutter, Thomas R ^a   Curphey, Thomas J ^b   Roebuck, Bill D ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLTIPRAZ;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DOSE CALCULATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; ENZYME INDUCTION; HUMAN; NONHUMAN; PHASE 1 CLINICAL TRIAL; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; CYTOCHROME P-450 ENZYME SYSTEM; DRUG APPROVAL; ENZYME INDUCTION; HUMANS; NEOPLASMS; PYRAZINES;

EID: 0033012855     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980185b     Document Type: Review

References (113)

1. Bailar, J. C., and Gornik, H. L. (1997) Cancer undefeated. N. Engl. J. Med. 336, 1569-1574.
2. Steele, V. E., Moon, R. C., Lubet, R. A., Grubbs, C. J., Reddy, B. S., Wargovich, M., McCormick, D. L., Perira, M. A., Crowell, J. A., Bagheri, D., Sigman, C. C., Boone, C. W., and Kelloff, G. J. (1994) Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemoprevention drug development program. J. Cell. Biochem. 20S, 32-54.
3. Sporn, M. B. (1996) The war on cancer. Lancet 347, 1377-1381.
4. Kelloff, G. J., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A., Greenwald, P., Alberts, D. S., Covey, J. M., Doody, L. A., Knapp, G. G., Nayfield, S., Parkinson, D. R., Prasad, V. K., Prorok, P. C., Sausville, E. A., and Sigman, C. C. (1994) Strategy and planning for chemopreventive drug development: clinical development plans. J. Cell. Biochem. 20S, 55-299.
5. Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., Hong, W. K., Parkinson, D. R., Bagheri, D., Baxter, G. T., Blunden, M., Doeltz, M. K., Eisenhauer, K. M., Johnson, K., Knapp, G. G., Longfellow, D. G., Malone, W. F., Nayfield, S. G., Seifried, H. E., Swall, L. M., and Sigman, C. C. (1996) Strategy and planning for chemopreventive drug development: clinical development plans II. J. Cell. Biochem. 26S, 54-315.
6. Kelloff, G. J., Johnson, J. R., Crowell, J. A., Boone, C. W., DeGeorge, J. J., Steele, V. E., Mehta, M. U., Temeck, J. W., Schmidt, W. J., Burke, G., Greenwald, P., and Temple, R. J. (1995) Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol. Biomarkers Prev. 4, 1-10.
7. Groopman, J. D., and Kensler, T. W. (1993) Molecular biomarkers for human chemical carcinogen exposures. Chem. Res. Toxicol. 6, 764-770.
8. Kelloff, G. J., Boone, C. W., Crowell, J. A., Nayfield, S. G., Hawk, E., Malone, W. F., Steele, V. E., Lubet, R. A., and Sigman, C. C. (1996) Risk biomarkers and current strategies for cancer chemoprevention. J. Cell. Biochem. 25S, 1-14.
9. Miller, E. C., and Miller, J. A. (1985) Some historical perspectives on the metabolism of xenobiotic chemicals to reactive intermediates. In Bioactivation of Foreign Compounds (Anders, M. W., Ed.) pp 1-28, Academic Press, New York.
10. Conney, A. H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875-4917.
11. Wattenberg, L. W. (1972) Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J. Natl. Cancer Inst. 48, 1425-1430.
12. Benson, A. M., Batzinger, R. P., Ou, S.-Y. L., Bueding, E., Cha, Y.-N., and Talalay, P. (1978) Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo[α]pyrene by dietary antioxidants. Cancer Res. 38, 4486-4495.
13. Talalay, P., DeLong, M. J., and Prochaska, H. J. (1987) Molecular mechanisms in protection against carcinogenesis. In Cancer Biology and Therapeutics (Cory, J. G., and Szentivanyi, A., Eds.) pp 197-216, Plenum, New York.
14. Kensler, T. W. (1997) Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect. 105S4, 965-970.
15. 1. In Principles of Chemoprevention (Stewart, B. W., McGregor, D., and Kleihues, P., Eds.) pp 175-187, International Agency for Cancer Research, Lyon, France.
16. Pezutto, J. M. (1997) Plant-derived anticancer agents. Biochem. Pharmacol. 53, 121-133.
17. Zhang, Y., Talalay, P., Cho, C.-G., and Posner, G. H. (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U.S.A. 89, 2399-2403.
18. Jirousek, L., and Starka, L. (1958) Uber das vorkommen von trithionen (1,2-dithiocyclopent-4-en-3-thione) in Brassicapflanzen. Naturwissenschaften 45, 386-387.
19. Marks, H. S., Leichtweis, H. C., and Stoewsand, G. S. (1991) Analysis of a reported organosulfur, carcinogenesis inhibitor: 1,2-dithiole-3-thione in cabbage. J. Agric. Food Chem. 39, 893-895.
20. Archer, S. (1985) The chemotherapy of schistosomiasis. Annu. Rev. Pharmacol. 25, 485-508.
21. Bueding, E., Dolan, P., and Leroy, J.-P. (1982) The antischistosomal activity of oltipraz. Res. Commun. Chem. Pathol. Pharmacol. 37, 293-303.
22. Ansher, S. S., Dolan, P., and Bueding, E. (1986) Biochemical effects of dithiolthiones. Food Chem. Toxicol. 24, 405-415.
23. Ansher, S. S., Dolan, P., and Bueding, E. (1983) Chemoprotective effects of two dithiolthiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity. Hepatology 3, 932-935.
24. 1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiolthione. Carcinogenesis 6, 759-763.
25. Wattenberg, L. W., and Bueding, E. (1986) Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) on carcinogenesis induced by benzo[α]pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis 7, 1379-1381.
26. Eaton, D. L., and Groopman, J. D., Eds. (1994) The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance, Academic Press, New York.
27. International Agency for Research on Cancer (1993) Some naturally occurring substances: food items and constituents, heteroxyclic aromatic amines and mycotoxins. IARC Monogr. Eval. Carcinog. Risk Chem. Man 56, 245-395.
28. Kensler, T. W., Egner, P. A., Dolan, P. M., Groopman, J. D., and Roebuck, B. D. (1987) Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 47, 4271-4277.
29. 1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res. 51, 5501-5506.
30. Wattenberg, L. W. (1985) Chemoprevention of cancer. Cancer Res. 45, 1-8.
31. 1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis 14, 2423-2425.
32. Bolton, M. G., Muñoz, A., Jacobson, L. P., Groopman, J. D., Maxuitenko, Y. Y., Roebuck, B. D., and Kensler, T. W. (1993) Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res. 53, 3499-3504.
33. Kensler, T. W., Gange, S. J., Egner, P. A., Dolan, P. M., Muñoz, A., Groopman, J. D., Rogers, A. E., and Roebuck, B. D. (1997) Predictive value of molecular dosimetry: Individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 6, 603-610.
34. Kensler, T. W., and Helzlsouer, K. J. (1995) Oltipraz: clinical opportunities for chemoprevention. J. Cell. Biochem. 22S, 101-107.
35. 14C-oltipraz in animals. Arzneim.-Forsch. 35, 1431-1436.
36. Moon, R. C., Kelloff, G. J., Detrisac, C. J., Steele, V. E., Thomas, C. F., and Sigman, C. C. (1994) Chemoprevention of OH-BBN induced bladder cancer in mice by oltipraz, alone or in combination with 4-HPR and DFMO. Anticancer Res. 14, 5-11.
37. Moon, R. C., Rao, K. V. N., Detrisac, C. J., Kelloff, G. J., Steele, V. E., and Doody, L. A. (1994) Chemoprevention of respiratory tract neoplasia in the hamster by oltipraz, alone and in combination. Int. J. Oncol. 4, 661-667.
38. Kensler, T. W., Davidson, N. E., Egner, P. A., Guyton, K. Z., Groopman, J. D., Curphey, T. J., Liu, Y.-L., and Roebuck, B. D. (1991) Protection against aflatoxin-induced hepatocarcinogenesis by dithiolethiones. In Mycotoxins, Cancer and Health (Bray, G. A., and Ryan, D. H., Eds.) pp 359-371, LSU Press, Baton Rouge, LA.
39. Meyer, D. J., Harris, J. M., Gilmore, K. S., Coles, B., Kensler, T. W., and Ketterer, B. (1993) Quantitation of tissue- and sex-specific induction of rat GSH transferase subunits by dietary 1,2-dithiole-3-thiones. Carcinogenesis 14, 567-572.
40. 1 exo- and endo-epoxides by rat and human glutathine S-transferases. Chem. Res. Toxicol. 5, 470-478.
41. 1 is expressed in rat liver during carcinogenesis and following administration of an antioxidant. Biochem. J. 292, 13-18.
42. Primiano, T., Gastel, J. A., Kensler, T. W., and Sutter, T. R. (1996) Isolation of cDNAs representing dithiolethione-responsive genes. Carcinogenesis 17, 2297-2303.
43. 1 in the rat. Toxicol. Appl. Pharmacol. 93, 442-451.
44. Buetler, T. M., Gallagher, E. P., Wang, C., Stahl, D. L., Hayes, J. D., and Eaton, D. L. (1995) Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol. Appl. Pharmacol. 135, 45-57.
45. 1 metabolism. FASEB J. 5, A1517.
46. 1 metabolism in human hepatocytes in primary culture. Cancer Res. 55, 5574-5579.
47. Gupta, E., Olopade, O. I., Ratain, M. J., Mick, R., Baker, T. M., Berezin, F. K., Benson, A. B., III, and Dolan, M. E. (1995) Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin. Cancer Res. 1, 1133-1138.
48. 1 excretion in rat urine during dietary intervention with oltipraz. Carcinogenesis 17, 1385-1388.
49. Primiano, T., Egner, P. A., Sutter, T. R., Kelloff, G. J., Roebuck, B. D., and Kensler, T. W. (1995) Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res. 55, 4319-4324.
50. O'Dwyer, P. J., Szarka, C. E., Yao, K.-S., Halbherr, T. C., Pfeiffer, G. R., Green, F., Gallo, J. M., Brennan, J., Frucht, H., Goosenberg, E. B., Hamilton, T. C., Litwin, S., Balshem, A. M., Engstrom, P. F., and Clapper, M. L. (1996) Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Invest. 98, 1210-1217.
51. Shiraki, H., and Guengerich, F. P. (1984) Turnover of membrane proteins: kinetics of induction and degradation of seven forms of rat liver microsomal cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydrolase. Arch. Biochem. Biophys. 235, 86-96.
52. Moon, R. C. (1988) Evaluation of chemopreventive agents by in vivo screening assays. Prepared for National Cancer Institute by IIT Research Institute under Contract N01-CN-55448-04. Final Report.
53. Rao, C. V., Rivenson, A., Katiwalla, M., Kelloff, G. J., and Reddy, B. S. (1993) Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoymethane in male F344 rats. Cancer Res. 53, 2502-2506.
54. Sutter, T. R., Guzman, K., Dodd, K. M., and Greenlee, W. F. (1991) Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science 254, 415-418.
55. Primiano, T., Kensler, T. W., Kuppusamy, P., Zweier, J. L., and Sutter, T. R. (1996) Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethiones. Carcinogenesis 17, 2291-2296.
56. Otieno, M., Guyton, K., and Kensler, T. W. (1998) Induction of manganese superoxide dimutase (MnSOD) and catalase mRNA by 1,2-dithiole-3-thione in vivo. Proc. Am. Assoc. Cancer Res. 39, 88.
57. Antras-Ferry, J., Mahéo, K., Chevanne, M., Dubois, M.-P., Morel, F., Guillouzo, A., Cillard, P., and Cillard, J. (1997) Oltipraz stimulates the transcription of the manganese superoxide gene in rat hepatocytes. Carcinogenesis 18, 2113-2117.
58. Prestera, T., Talalay, P., Alam, J., Ahn, Y. I., Lee, P. J., and Choi, A. M. (1995) Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophile and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol. Med. 1, 827-837.
59. 4 12-dehydrogenase: implications for chemoprevention. Carcinogenesis 19, 999-1005.
60. 4, a potent chemotactic and aggregating substance released from polymorphonuclear leukocytes. Nature 286, 264-265.
61. Mansuy, D., Sassi, A., Dansette, P. M., and Plat, M. (1986) A new potent inhibitor of lipid peroxidation in vitro and in vivo, the heptoprotective drug anisyldithiolthione. Biochem. Biophys. Res. Commun. 135, 1015-1021.
62. Anderson, L., Steele, V. K., Kelloff, G. J., and Sharma, S. (1995) Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver. J. Cell. Biochem. 22S, 108-116.
63. O'Dwyer, P. J., Johnson, S. W., Khater, C., Kruger, A., Matsumoto, Y., Hamilton, T. C., and Yao, K.-S. (1997) The chemopreventive agent oltipraz stimulates repair of damaged DNA. Cancer Res. 57, 1050-1053.
64. Christen, M.-O. (1995) Anethole Dithiolethione: biochemical considerations. Biothiols Part B. Glutathione and Thioredoxin, Thiols in Signal Transduction and Gene Regulation. Methods Enzymol. 252, 316-340.
65. Davidson, N. E., Egner, P. A., and Kensler, T. W. (1990) Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res. 50, 2251-2255.
66. Morel, F., Fardel, O., Meyer, D. J., Langouët, S., Gilmore, K. S., Meunier, B., Tu, C.-P. D., Kensler, T. W., Ketterer, B., and Guillouzo, A. (1993) Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene and dithiolethiones. Cancer Res. 53, 231-234.
67. Prochaska, H. J., and Talalay, P. (1988) Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48, 4776-4782.
68. Fisher, J. M., Wu, L., Denison, M. S., and Whitlock, J. P., Jr. (1990) Organization and function of a dioxin-responsive enhancer. J. Biol. Chem. 265, 9676-9681.
69. Talalay, P., DeLong, M. J., and Prochaska, H. J. (1988) Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 85, 8261-8265.
70. Prestera, T., Holtzclaw, W. D., Zhang, Y., and Talalay P. (1993) Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. U.S.A. 90, 2965-2969.
71. Egner, P. A., Kensler, T. W., Prestera, T., Talalay, P., Libby, A. H., Joyner, H. H., and Curphey, T. J. (1994) Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 15, 177-181.
72. 1-induced hepatic toxicity as a short term screen for cancer chemopreventive dithiolethiones. Fundam. Appl. Toxicol. 32, 250-259.
73. Fleury, M.-B., Largeron, M., and Martins, T. (1991) Toward an understanding of the schisosomicidal effect of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz). Biochem. Pharmacol. 41, 361-367.
74. Chavan, S. J., Bornmann, W. G., Flexner, C., and Prochaska, H. J. (1996) Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct. Arch. Biochem. Biophys. 324, 143-152.
75. Kim, W., and Gates, K. S. (1997) Evidence for thiol-dependent production of oxygen radicals by 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (oltipraz) and 3H-1,2-dithiole-3-thione: possible relevance to the anticarcinogenic properties of 1,2-dithiole-3-thiones. Chem. Res. Toxicol. 10, 296-301.
76. Primiano, T., Sutter, T. R., and Kensler, T. W. (1997) Redox regulation of genes that protect against carcinogens. Comp. Biochem. Physiol. 118B, 487-497.
77. Friling, R. S., Bensimon, A., Tichauer, Y., and Daniel, V. (1990) Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. U.S.A. 87, 6258-6262.
78. Rushmore, T. H., King, R. G., Paulson, K. E., and Pickett, C. B. (1990) Regulation of glutathione S-transferase Ya subunit gene expression: Identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. U.S.A. 87, 3826-3830.
79. Jaiswal, A. K. (1994) Antioxidant response element. Biochem. Pharmacol. 48, 439-444.
80. Wasserman, W. W., and Fahl, W. E. (1997) Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. U.S.A. 94, 5361-5366.
81. Chan, J. Y., Han, X., and Kan, Y. W. (1993) Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc. Natl. Acad. Sci. U.S.A. 90, 11366-11370.
82. Moi, P., Chan, K., Asunis, I., Cao, A., and Kan, Y. W. (1993) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region. Proc. Natl. Acad. Sci. U.S.A. 91, 9926-9930.
83. 1 gene. Proc. Natl. Acad. Sci. U.S.A. 93, 14960-14965.
84. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., and Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through anitoxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
85. Groopman, J. D., Donahue, P. R., Zhu, J., Chen, J.-S., and Wogan, G. N. (1985) Aflatoxin metabolism in humans: detection of metabolites and nucleaic acid adducts in urine by affinity chromatography. Proc. Natl. Acad. Sci. U.S.A. 82, 6492-6496.
86. 1. Carcinogenesis 9, 1323-1325.
87. Wild, C. P., Hudson, G. J., Sabbioni, G., Chapot, B., Hall, A. J., Wogan, G. N., Whittle, H., Montesano, R., and Groopman, J. D. (1992) Dietary intake of aflatoxins and the level of alfumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol. Biomarkers Prey. 1, 229-234.
88. 1 in a survey of mainland China and Taiwan. Cancer Epidemiol. Biomarkers Prev. 6, 523-529.
89. 1 mercapturic acids and their identification in rat urine. Chem. Res. Toxicol. 10, 1144-1151.
90. Skipper, P. L., and Tannenbaum, S. R. (1990) Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11, 507-518.
91. Kensler, T. W., Groopman, J. D., and Wogan, G. N. (1996): Carcinogen-DNA and protein adduct biomarkers for cohort selection and as modifiable endpoints in chemoprevention trials. In IARC Scientific Publication No. 139: Principles of Chemoprevention (Stewart, B. W., McGregor, D., and Kleihues, P., Eds.) pp 237-248, International Agency for Research on Cancer, Lyon, France.
92. Groopman, J. D., and Kensler, T. W. (1999) The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis 20, 1-11.
93. Egner, P. A., Gange, S. J., Dolan, P. M., Groopman, J. D., Muñoz, A., and Kensler, T. W. (1995) Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Carcinogenesis 16, 1769-1773.
94. 1 in human urine. Cancer Res. 47, 1848-1852.
95. Groopman, J. D., Zhu, J.-Q., Donahue, P. R., Pikul, A., Zhang, L.-S., Chen, J.-S., and Wogan, G. N. (1992) Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res. 52, 45-52.
96. Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J.-M., Gao, Y.-T., Henderson, B. E., Wogan, G. N., and Groopman, J. D. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3, 3-10.
97. Yu, M.-W., Lien, J.-P., Chiu, Y.-H., Santella, R. M., Liaw, Y.-F., and Chen, C.-J. (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. Hepatology 27, 320-330.
98. Zhu, Y.-R., Chen, J.-G., and Huang, X. Y. (1989) Hepatocellular carcinoma in Qidong County. In Primary Liver Cancer (Tang, Z. Y., Ed.) pp 204-222, China Academic Publisher and Springer-Verlag, Beijing, PRC.
99. Yu, S.-Z. (1995) Primary prevention of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 10, 674-682.
100. Zarba, A., Qian, G.-S., Zhu, Y.-R., Muñoz, A., Kensler, T. W., and Groopman, J. D. (1995) Assessment of nutrient intake among carriers and non-carriers of hepatitis B surface antigen in Daxin Township, Qidong County, PRC. Proc. Am. Assoc. Cancer Res. 36, 277.
101. Ross, R. K., Yuan, J.-M., Yu, M. C., Wogan, G. N., Qian, G.-S., Tu, J.-T., Groopman, J. D., Gao, Y.-T., and Henderson, B. E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339, 943-946.
102. Wang, J.-S., Qian, G.-S., Zarba, A., He, X., Zhu, Y.-R., Zhang, B.-C., Jacobson, L., Gange, S. J., Muñoz, A., Kensler, T. W., and Groopman, J. D. (1996) Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 5, 253-261.
103. Kuang, S.-Y., Fang, X., Lu, P.-X., Zhang, Q.-N., Wu, Y., Wang, J.-B., Zhu, Y.-R., Groopman, J. D., Kensler, T. W., and Qian, G.-S. (1996) Aflatoxin-albumin adducts and risk for hepatocellular carcinoma in residents of Qidong, People's Republic of China. Proc. Am. Assoc. Cancer Res. 37, 252.
104. Wang, L.-Y., Hatch, M., Chen, C.-J., Levin, B., You, S.-L., Lu, S.-N., Wu, M.-H., Wu, W.-P., Wang, L.-W., Wang, Q., Huang, G.-T., Yang, P.-M., Lee, H.-S., and Santella, R. M. (1996) Aflatoxin exposure and the risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 67, 620-625.
105. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
106. 1 induces the transversion of G to T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90, 8586-8590.
107. Chang, M. H., Chen, C. J., Lai, M. S., Hsu, H. M., Wu, T. C., Kong, M. S., Liang, D. C., Shau, W. Y., and Chen, D. S. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N. Engl. J. Med. 336, 1855-1859.
108. Benson, A. B., III (1993) Oltipraz: a laboratory and clinical review. J. Cell. Biochem. 17F, 278-291.
109. Jacobson, L. P., Zhang, B.-C., Zhu, Y.-R., Wang, J.-B., Wu, Y., Zhang, Q.-N., Yu, L.-Y., Qian, G.-S., Kuang, S.-Y., Li, Y.-F., Fang, X., Zarba, A., Chen, B., Enger, C., Davidson, N. E., Gorman, M. B., Gordon, G. B., Prochaska, H. J., Egner, P. A., Groopman, J. D., Muñoz, A., Helzlsouer, K. J., and Kensler, T. W. (1997) Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol. Biomarkers Prev. 6, 257-265.
110. Kensler, T. W., He, X., Otieno, M., Egner, P. A., Jacobson, L. P., Chen, B., Wang, J.-S., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-Y., Fang, X., Li, Y.-F., Yu, L.-Y., Prochaska, H. J., Davidson, N. E., Gordon, G. B., Gorman, M. B., Zarba, A., Enger, C., Muñoz, A., Helzlsover, K. J., and Groopman, J. D. (1998) Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomarkers Prev. 7, 127-134.
111. 1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl. Cancer Inst. (in press).
112. Maxiutenko, Y. Y., Curphey, T. J., Libby, A. H., Joyner, H. H., MacMillan, D. L., Kensler, T. W., and Roebuck, B. D. (1998) Identification of dithiolethiones with better chemopreventive properties than oltipraz. Carcinogenesis 19, 1609-1615.
113. Prochaska, H. J., Santamaria, A. B., and Talalay, P. (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. U.S.A. 89, 2394-2398.